Skip Navigation

JNCI Journal of the National Cancer Institute 2003 95(20):1556-1557; doi:10.1093/jnci/djg089
© 2003 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Leitzmann, M. F.
Right arrow Articles by Giovannucci, E. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Leitzmann, M. F.
Right arrow Articles by Giovannucci, E. L.
Related Collections
Right arrowCorrespondence about this Article
Right arrowRelated Article in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2003 Oxford University Press

CORRESPONDENCE

RESPONSE: Re: Zinc Supplement Use and Risk of Prostate Cancer

Michael F. Leitzmann, Edward L. Giovannucci

Affiliations of authors: M. F. Leitzmann, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD; E. L. Giovannucci, Departments of Nutrition and Epidemiology, Harvard School of Public Health, Boston, MA.

Correspondence to: Michael F. Leitzmann, MD, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd., EPS-MSC 7232, Bethesda, MD 20892 (e-mail: leitzmann@mail.nih.gov).

The first 10% of the full text of this article appears below.

Krone and Harms suggest that the apparent adverse effect of zinc supplements on advanced prostate cancer risk is due to contamination of zinc supplements by cadmium. Cadmium exposure has not been consistently associated with . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Correspondence about this Article

Re: Zinc Supplement Use and Risk of Prostate Cancer
Cheryl A. Krone and Louis C. Harms
J Natl Cancer Inst 2003 95: 1556. [Extract] [Full Text] [PDF]

Related Article in JNCI

Zinc Supplement Use and Risk of Prostate Cancer
Michael F. Leitzmann, Meir J. Stampfer, Kana Wu, Graham A. Colditz, Walter C. Willett, and Edward L. Giovannucci
J Natl Cancer Inst 2003 95: 1004-1007. [Abstract] [Full Text] [PDF]